Replies to post #23813 on Mymetics Corp (MYMX)

[bow-tie]

New adjuvant helps induce long-lasting immunity against HIV

Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today in Science Immunology.

https://www.news-medical.net/news/20200620/New-adjuvant-helps-induce-long-lasting-immunity-against-HIV.aspx

Mymetics Corporation (MYMX): 3M-052 as an adjuvant for a PLGA ...
investorshub.advfn.com › boards › read_msg
3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine... (TLR) 7/8 agonist 3M-052 in combination with the Leishmania donovani 36-kDa nucleoside...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964269


New GMP manufacturing processes to obtain thermostable HIV-1 ...
pubmed.ncbi.nlm.nih.gov › 32435515
The HIV-1 gp41-derived antigens anchored in the virosome membrane, along with the adjuvant 3M-052 (TLR7/8 agonist) on the same particle, served as a candidate vaccine for the proof of concept for establishing manufacturing processes, which can be directly applied or adapted to other virosomal vaccines or lipid-based particles.

https://pubmed.ncbi.nlm.nih.gov/32435515/

Hungry Hippo
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151753105

[Work Harder]

East Bay biotech signs on with Chinese Covid-19 vaccine maker

https://www.bizjournals.com/sanfrancisco/news/2021/02/01/covid-19-vaccine-coronavirus-dynavax-clover-bio.html

https://fintel.io/so/us/dvax

Clover Biopharmaceuticals has raised more than USD $350 million in total capital since 2016